Westwater Resources, Inc. Announces Results for Third Quarter Ended September 30, 2022
Company Announces Strong Progress in Meeting Construction Milestones Company Reports Increased Customer Interest Resulting from…
3 years ago
Wire Stories
Westwater Resources, Inc. Announces Results for Third Quarter Ended September 30, 2022
Company Announces Strong Progress in Meeting Construction Milestones Company Reports Increased Customer Interest Resulting from…
3 years ago
Global Blue Releases the Monthly Tax Free Shopping Business Update for October 2022
SIGNY, Switzerland--(BUSINESS WIRE)--Fresh data from Global Blue reveals that the dynamic recovery for Tax Free…
3 years ago
Global Blue Releases the Monthly Tax Free Shopping Business Update for October 2022
SIGNY, Switzerland--(BUSINESS WIRE)--Fresh data from Global Blue reveals that the dynamic recovery for Tax Free…
3 years ago
TDCX Inc. to Report Third Quarter 2022 Results on Tuesday, November 22, 2022
SINGAPORE--(BUSINESS WIRE)--TDCX Inc. (“TDCX” or the “Company”) (NYSE: TDCX), an award-winning digital customer experience solutions…
3 years ago
Global Blue Releases the Monthly Tax Free Shopping Business Update for October 2022
SIGNY, Switzerland--(BUSINESS WIRE)--Fresh data from Global Blue reveals that the dynamic recovery for Tax Free…
3 years ago
Options Appoint Christy O’Kane to SVP, Global Head of Delivery
LONDON & NEW YORK & HONG KONG--(BUSINESS WIRE)--Options Technology, the leading Capital Markets services provider,…
3 years ago
TDCX Inc. to Report Third Quarter 2022 Results on Tuesday, November 22, 2022
SINGAPORE--(BUSINESS WIRE)--TDCX Inc. (“TDCX” or the “Company”) (NYSE: TDCX), an award-winning digital customer experience solutions…
3 years ago
Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov. 10 – 14, in Philadelphia, PA
ABP-671 effective at lowering serum uric acid, the cause of gout JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience, a…
3 years ago
Atom Bioscience to Present Final Data from its Positive Phase 2a Clinical Trial in Chronic Gout at American College of Rheumatology Annual Meeting, Nov. 10 – 14, in Philadelphia, PA
ABP-671 effective at lowering serum uric acid, the cause of gout JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience, a…
3 years ago